These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9617492)

  • 1. Serum ferritin levels are increased in patients with acute renal failure.
    Mavromatidis K; Fytil C; Kynigopoulou P; Fragia T; Sombolos K
    Clin Nephrol; 1998 May; 49(5):296-8. PubMed ID: 9617492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
    Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum ferritin in renal insufficiency, hemodialysis and kidney transplantation].
    Hofmann V; Descoeudres C; Montandon A; Galeazzi RL; Straub PW
    Schweiz Med Wochenschr; 1978 Nov; 108(47):1835-8. PubMed ID: 362527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
    Labonia W; Rubio D; Arias C
    Nephrology (Carlton); 2005 Dec; 10(6):583-7. PubMed ID: 16354241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin and other iron indices in adult Nigerians with chronic renal failure--review of management of anaemia.
    Oluboyede OA; Williams AI
    Afr J Med Med Sci; 1995 Sep; 24(3):231-7. PubMed ID: 8798957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
    Docci D; Cenciotti L; Turci F; Salvi G; Mosconi G; Baldrati L
    Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of ARF after cardiac surgical procedures.
    Tuttle KR; Worrall NK; Dahlstrom LR; Nandagopal R; Kausz AT; Davis CL
    Am J Kidney Dis; 2003 Jan; 41(1):76-83. PubMed ID: 12500223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia following renal transplantation: erythropoietin response and iron deficiency.
    Miles AM; Markell MS; Daskalakis P; Sumrani NB; Hong J; Sommer BG; Friedman EA
    Clin Transplant; 1997 Aug; 11(4):313-5. PubMed ID: 9267720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
    Mitsuiki K; Harada A; Miyata Y
    Clin Exp Nephrol; 2004 Sep; 8(3):257-62. PubMed ID: 15480904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.